Notably, we found increased IFN-γ release to all screened epitopes in the global cohort of patients if compared with healthy donors, demonstrating the existence of spontaneous T cell responses against multiple TAA in locally advanced breast cancer patients. The gene discussed is IFNG; the disease is breast carcinoma.